SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
BIOTECH: Hybritech’s Story Is First Chapter of S.D.’s Biotech Biography
The name Hybritech is pinned to local resumes like a badge of honor, as if to say, “I was here in the beginning.”
OncoSec Medical Inc., a company developing cancer immunotherapies, announced Thursday the appointment of Richard B. Slansky as chief financial officer effective July 6.
Palomar Health's Board of Directors voted Wednesday night to close Palomar Health Downtown Hospital in Escondido.
San Diego-based Aethlon Medical Inc., a medical device company developing therapies for infectious diseases and cancer, announced Wednesday that it entered into a definitive $6 million stock purchase agreement.
ARK Animal Health Inc., a wholly-owned subsidiary of San Diego-based Sorrento Therapeutics Inc., was granted a Minor Use/Minor Species (MUMS) Drug Designation for its pain drug, ARK-001, for dogs with bone cancer.
The Sanford-Burnham Medical Research Institute announced Wednesday that it has received a gift of $100 million from prominent San Diego developer and philanthropist Conrad Prebys.
Imprimis Pharmaceuticals Inc. has acquired the rights to novel sedation and analgesia/anesthesia formulations that can block pain and sedate patients undergoing ocular and other surgical procedures.
San Diego’s AMN Healthcare Services, the country’s largest provider of health care staffing services, has won a sole source contract with Premier Inc. to offer staffing services and workforce solutions to its alliance of about 3,400 hospitals and 110,000 other health care facilities.
Ambrx Inc., a San-Diego based biotechnology company, has named Tiecheng (Alex) Qiao its CEO effective immediately.
HEALTH: Devices Could Be Game Changer for Health Care, Expert Says
Apple’s latest gadget ― the iWatch ― has spurred a massive influx of digital health companies to enter the already popular wearables market, industry analysts said.
San Diego-based aTyr Pharma Inc. reported a net loss of $9.1 million for the first quarter of 2015, up from a net loss of $6.2 million in the same period last year.
The Pew Charitable Trusts announced recently that Salk Institute for Biological Studies scientist Nicola Allen, an assistant professor in the Molecular Neurobiology Laboratory, is one of 22 researchers to be named a Pew Scholar in the biomedical sciences.
San Diego 3-D bioprinting company Organovo Holdings Inc. announced Thursday a $40 million underwritten public offering of its common stock.
San Diego State University College of Sciences and the University of San Diego School of Law are partnering on a new program that prepares students for upward career mobility in the growing life sciences industry.
Batu Biologics, an immuno-oncology company, announced Wednesday that it has successfully completed a $1 million seed round of funding.